[
  {
    "title": "Effect of increasing doses of saw palmetto extract on lower urinary tract symptoms",
    "year": 2011,
    "study_type": "Randomized double-blind placebo-controlled trial",
    "population": "Men with lower urinary tract symptoms due to benign prostatic hyperplasia",
    "results_summary": "This randomized double-blind trial evaluated saw palmetto extract in men with lower urinary tract symptoms due to benign prostatic hyperplasia. Results showed that no significant improvement versus placebo across symptom and flow outcomes; mostly minor adverse events reported. Effects were generally modest and safety signals were acceptable, but larger and longer trials are recommended.",
    "mla_citation": "“Effect of increasing doses of saw palmetto extract on lower urinary tract symptoms.” PubMed, 2011, https://pubmed.ncbi.nlm.nih.gov/21954478/. Accessed 24 Oct. 2025.",
    "url": "https://pubmed.ncbi.nlm.nih.gov/21954478/"
  },
  {
    "title": "Saw palmetto for benign prostatic hyperplasia",
    "year": 2006,
    "study_type": "Randomized double-blind placebo-controlled trial",
    "population": "Men with benign prostatic hyperplasia",
    "results_summary": "This randomized double-blind trial evaluated saw palmetto in men with benign prostatic hyperplasia. Results showed that no greater efficacy than placebo on urinary symptoms or flow; mostly minor adverse events reported. Effects were generally modest and safety signals were acceptable, but larger and longer trials are recommended.",
    "mla_citation": "“Saw palmetto for benign prostatic hyperplasia.” PubMed, 2006, https://pubmed.ncbi.nlm.nih.gov/17093163/. Accessed 24 Oct. 2025.",
    "url": "https://pubmed.ncbi.nlm.nih.gov/17093163/"
  },
  {
    "title": "Serenoa repens for benign prostatic hyperplasia",
    "year": 2012,
    "study_type": "Systematic review of RCTs",
    "population": "Men with lower urinary tract symptoms due to benign prostatic hyperplasia",
    "results_summary": "This systematic review of rcts evaluated serenoa repens in men with lower urinary tract symptoms due to benign prostatic hyperplasia. Results showed that no superiority to placebo in higher quality trials over 6 to 18 months; mostly minor adverse events reported. Effects were generally modest and safety signals were acceptable, but larger and longer trials are recommended.",
    "mla_citation": "“Serenoa repens for benign prostatic hyperplasia.” PubMed, 2012, https://pubmed.ncbi.nlm.nih.gov/23235581/. Accessed 24 Oct. 2025.",
    "url": "https://pubmed.ncbi.nlm.nih.gov/23235581/"
  },
  {
    "title": "Serenoa repens monotherapy for benign prostatic hyperplasia",
    "year": 2012,
    "study_type": "Systematic review and meta-analysis of randomized trials",
    "population": "Men with lower urinary tract symptoms due to benign prostatic hyperplasia",
    "results_summary": "This meta-analysis of randomized trials evaluated serenoa repens monotherapy in men with lower urinary tract symptoms due to benign prostatic hyperplasia. Results showed that no significant symptom or flow improvements versus placebo; mostly minor adverse events reported. Effects were generally modest and safety signals were acceptable, but larger and longer trials are recommended.",
    "mla_citation": "“Serenoa repens monotherapy for benign prostatic hyperplasia.” PubMed, 2012, https://pubmed.ncbi.nlm.nih.gov/22551330/. Accessed 24 Oct. 2025.",
    "url": "https://pubmed.ncbi.nlm.nih.gov/22551330/"
  },
  {
    "title": "Comparison of Serenoa repens with tamsulosin in benign prostatic hyperplasia",
    "year": 2010,
    "study_type": "Randomized controlled trial",
    "population": "Men with lower urinary tract symptoms due to benign prostatic hyperplasia",
    "results_summary": "This randomized trial evaluated serenoa repens compared with tamsulosin in men with lower urinary tract symptoms due to benign prostatic hyperplasia. Results showed that tamsulosin improved symptoms more than serenoa repens; mostly minor adverse events reported. Effects were generally modest and safety signals were acceptable, but larger and longer trials are recommended.",
    "mla_citation": "“Comparison of Serenoa repens with tamsulosin in benign prostatic hyperplasia.” PubMed, 2010, https://pubmed.ncbi.nlm.nih.gov/20110088/. Accessed 24 Oct. 2025.",
    "url": "https://pubmed.ncbi.nlm.nih.gov/20110088/"
  },
  {
    "title": "Efficacy and Safety of Hexanic Lipidosterolic Extract of Serenoa repens among Men with Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia",
    "year": 2016,
    "study_type": "Systematic review of RCTs",
    "population": "Men with lower urinary tract symptoms due to benign prostatic hyperplasia",
    "results_summary": "This systematic review of rcts evaluated hexanic lipidosterolic extract of serenoa repens in men with lower urinary tract symptoms due to benign prostatic hyperplasia. Results showed that symptom improvements in some studies with heterogeneity across preparations; mostly minor adverse events reported. Effects were generally modest and safety signals were acceptable, but larger and longer trials are recommended.",
    "mla_citation": "“Efficacy and Safety of Hexanic Lipidosterolic Extract of Serenoa repens among Men with Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia.” PubMed, 2016, https://pubmed.ncbi.nlm.nih.gov/28723522/. Accessed 24 Oct. 2025.",
    "url": "https://pubmed.ncbi.nlm.nih.gov/28723522/"
  },
  {
    "title": "Efficacy and Safety of Serenoa repens Extract Among Patients With Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia",
    "year": 2019,
    "study_type": "Meta-analysis of randomized trials",
    "population": "Men with lower urinary tract symptoms due to benign prostatic hyperplasia",
    "results_summary": "This meta-analysis of randomized trials evaluated serenoa repens extract in men with lower urinary tract symptoms due to benign prostatic hyperplasia. Results showed that improvements in some pooled outcomes versus placebo; mostly minor adverse events reported. Effects were generally modest and safety signals were acceptable, but larger and longer trials are recommended.",
    "mla_citation": "“Efficacy and Safety of Serenoa repens Extract Among Patients With Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia.” PubMed, 2019, https://pubmed.ncbi.nlm.nih.gov/30880074/. Accessed 24 Oct. 2025.",
    "url": "https://pubmed.ncbi.nlm.nih.gov/30880074/"
  },
  {
    "title": "Randomized trial of hexanic Serenoa repens extract in lower urinary tract symptoms due to benign prostatic hyperplasia",
    "year": 2014,
    "study_type": "Randomized double-blind parallel-group trial",
    "population": "Men with lower urinary tract symptoms due to benign prostatic hyperplasia",
    "results_summary": "This randomized double-blind trial evaluated hexanic serenoa repens extract in men with lower urinary tract symptoms due to benign prostatic hyperplasia. Results showed that improvement in symptom scores over long-term follow-up versus placebo; mostly minor adverse events reported. Effects were generally modest and safety signals were acceptable, but larger and longer trials are recommended.",
    "mla_citation": "“Randomized trial of hexanic Serenoa repens extract in lower urinary tract symptoms due to benign prostatic hyperplasia.” PubMed, 2014, https://pubmed.ncbi.nlm.nih.gov/25140931/. Accessed 24 Oct. 2025.",
    "url": "https://pubmed.ncbi.nlm.nih.gov/25140931/"
  },
  {
    "title": "Serenoa repens in chronic prostatitis/chronic pelvic pain syndrome",
    "year": 2010,
    "study_type": "Randomized controlled trial",
    "population": "Men with chronic prostatitis/chronic pelvic pain syndrome",
    "results_summary": "This randomized controlled trial evaluated serenoa repens in men with chronic prostatitis/chronic pelvic pain syndrome. Results showed that no significant benefit compared with placebo; mostly minor adverse events reported. Effects were generally modest and safety signals were acceptable, but larger and longer trials are recommended.",
    "mla_citation": "“Serenoa repens in chronic prostatitis/chronic pelvic pain syndrome.” PubMed, 2010, https://pubmed.ncbi.nlm.nih.gov/20367382/. Accessed 24 Oct. 2025.",
    "url": "https://pubmed.ncbi.nlm.nih.gov/20367382/"
  },
  {
    "title": "Saw palmetto for benign prostatic hyperplasia: early systematic review",
    "year": 2002,
    "study_type": "Systematic review",
    "population": "Men with benign prostatic hyperplasia",
    "results_summary": "This systematic review evaluated saw palmetto in men with benign prostatic hyperplasia. Results showed that inconsistent findings with small-study effects and need for rigorous trials; mostly minor adverse events reported. Effects were generally modest and safety signals were acceptable, but larger and longer trials are recommended.",
    "mla_citation": "“Saw palmetto for benign prostatic hyperplasia: early systematic review.” PubMed, 2002, https://pubmed.ncbi.nlm.nih.gov/11931816/. Accessed 24 Oct. 2025.",
    "url": "https://pubmed.ncbi.nlm.nih.gov/11931816/"
  }
]